Mark R. Goodman, a Partner in Freeborn's Corporate Practice Group, recently authored "PERSPECTIVES: NIMA, SLIMPACT benefit different surplus lines constituencies," which was published in Business Insurance's Speciality Risks section on October 18, 2011.
Click here to read the article.
